OakChart

Penumbra Inc

PENHealthcare·Medical Devices·USA·Large·NYSE·Nov 11 • 1:29 PM ET

321.80+0.34 (0.11%)
2026-11-11 19:29 CET
Market cap
12,670.15 USD m
Revenue, TTM
1,560.33 USD m
Net income, TTM
157.02 USD m
Free cash flow, TTM
200.29 USD m
EPS diluted, TTM
3.97
P/E
81.00
Compare

Price

PEN against its 20, 50 and 200-day averages
2050200beatmiss
300.00310.00320.00330.00497K994KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PENclose 321.8020-day 321.9750-day 320.19200-day 326.08321.80

11.2% under the 52-week high of 362.41 on 21 Jan 2026. 52-week low 271.32 on 11 Nov 2025. Last 15 sessions, 2.9% high to low

Profile

PEN
52-week range, 55% of the way up
271.32362.41

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

IndexRUI
Employees4700
IPOSep 18, 2015
Beta0.69
ATR, 14d2.65
Rel volume0.82
Short float6.28%
Insider own2.87%
Inst own86.74%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap12.68B
Enterprise Value12.22B
Income157.02M
Sales1.56B
Book/sh40.18
Cash/sh17.09
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees4700
IPOSep 18, 2015

Ratios

P/E81.00
Forward P/E53.89
PEG2.46
P/S8.13
P/B8.01
P/C18.83
P/FCF63.33
EV/EBITDA58.37
EV/Sales7.83
Quick Ratio3.92
Current Ratio5.89
Debt/Eq0.13
LT Debt/Eq0.12
Option/ShortYes / Yes

Earnings

EPS (ttm)3.97
EPS next Y5.97
EPS next Q1.44
EPS this Y22.57%
EPS next Y26.87%
EPS next 5Y21.92%
EPS past 3/5Y- -
Sales past 3/5Y18.33% 20.16%
EPS Y/Y TTM-5.62%
Sales Y/Y TTM16.98%
EPS Q/Q-8.53%
Sales Q/Q15.64%
EarningsOct 29 AMC
EPS/Sales Surpr.-11.09% 2.18%

Ownership

Insider Own2.87%
Insider Trans0.00%
Inst Own86.74%
Inst Trans1.92%
ROA8.33%
ROE10.67%
ROIC8.84%
Gross Margin66.71%
Oper. Margin12.13%
Profit Margin10.06%
SMA20-0.05%
SMA500.50%
SMA200-1.31%
Trades-

Technical

Shs Outstand39.41M
Shs Float38.28M
Short Float6.28%
Short Ratio6.82
Short Interest2.40M
52W High362.41 -11.21%
52W Low271.32 18.61%
Volatility0.85% 0.78%
ATR (14)2.65
RSI (14)51.66
Beta0.69
Rel Volume0.82
Avg Volume352.14K
Volume182,652

Performance

Perf Week-0.20%
Perf Month0.56%
Perf Quarter-1.51%
Perf Half Y-0.24%
Perf YTD3.50%
Perf Year15.06%
Perf 3Y77.36%
Perf 5Y21.61%
Perf 10Y402.81%
Recom2.80
Target Price362.86
Prev Close321.46
Price321.80
Change %0.11%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Dec 18, 2025UpgradeJJP MorganNeutral → Overweight$370+15.0%
Dec 11, 2025UpgradeCCitigroupNeutral → Buy$350+8.8%
Nov 18, 2025InitiatedWWells FargoUnderweight$15-95.3%
Oct 08, 2025UpgradeNNeedhamHold → Buy$326+1.3%
Sep 02, 2025InitiatedEEvercore ISIOutperform$300-6.8%
Mar 14, 2025InitiatedBBofA SecuritiesBuy$320-0.6%
Jan 21, 2025InitiatedUUBSBuy$305-5.2%
Dec 17, 2024InitiatedOOppenheimerOutperform$275-14.5%
Dec 11, 2024UpgradeWWells FargoEqual Weight → Overweight$190 → $275-14.5%
Sep 18, 2024InitiatedSStifelBuy$238-26.0%

Peers

Mkt cap
TickerCompanyMkt cap
SYKStryker Corp121.19B
BSXBoston Scientific Corp65.80B
MDTMedtronic Plc129.33B
EWEdwards Lifesciences Corp60.27B
ANGOAngiodynamic Inc515.59M
MMSIMerit Medical Systems Inc5.26B
TFXTeleflex Incorporated6.17B
IARTIntegra Lifesciences Holdings Corp1.16B
NSPRInspireMD Inc38.11M
LMATLemaitre Vascular Inc1.81B

Insider trading

latest 14 of 18
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Grewal HarpreetDirectorApr 02 '26Sale328.2210032,8228,719Apr 06 08:02 PM
Grewal HarpreetDirectorApr 02 '26Proposed Sale328.2210032,822Apr 02 03:59 PM
Yuen MaggieChief Financial OfficerMar 02 '26Sale342.302,432832,47418,353Mar 04 07:31 PM
MAGGIE YUENOfficerMar 02 '26Proposed Sale342.302,432832,474Mar 02 04:11 PM
Grewal HarpreetDirectorJan 06 '26Sale312.6418658,1518,230Jan 08 09:06 PM
Wilder ThomasDirectorJan 02 '26Sale310.7218657,7940Jan 06 07:33 PM
Grewal HarpreetDirectorJan 06 '26Proposed Sale312.6418658,151Jan 06 03:52 PM
THOMAS WILDERDirectorJan 02 '26Proposed Sale310.7218657,794Jan 02 04:02 PM
Bose AraniDirectorDec 11 '25Sale308.8215,0004,632,292258,462Dec 15 07:30 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryDec 05 '25Sale300.1330090,03963,836Dec 09 08:01 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryDec 01 '25Sale294.94600176,96664,136Dec 03 07:45 PM
Grewal HarpreetDirectorDec 02 '25Sale292.9810029,2988,416Dec 03 07:44 PM
Grewal HarpreetDirectorDec 02 '25Proposed Sale292.9810029,298Dec 02 03:59 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryNov 25 '25Sale300.061,800540,10864,736Nov 26 07:36 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IJKiShares S&P Mid-Cap 400 Growth ETFAUM: 10.46B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.90B
IWPiShares Russell Mid-Cap Growth ETFAUM: 18.09B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-291.0701.2041.070410.15401.417
2026Q22026-07-300.8801.1630.880390.05389.648
2026Q12026-05-060.8201.0380.824374.76370.477
2025Q42026-02-251.1801.1121.202385.39361.8719
2025Q32025-11-050.9700.9291.167354.69340.9519
2025Q22025-07-290.8600.8251.154339.46327.7619
2025Q12025-04-230.8300.6671.002324.1315.719
2024Q42025-02-180.9700.8960.863321.32311.4418
2024Q32024-10-300.8500.6870.754301.04297.3617
2024Q22024-07-300.6400.556-1.552299.4298.2414
2024Q12024-05-070.4100.3860.279278.66275.214
2023Q42024-02-220.7600.6991.380284.68286.6214
2023Q32023-11-020.6700.4540.235270.95265.3814
2023Q22023-08-010.4300.2800.484261.5253.5913
2023Q12023-05-020.2300.1090.219241.4229.6812
2022Q42023-02-230.1600.1460.100221.22217.3312

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY0.1800.3670.183444.94439.2
2019FY1.3401.0021.336547.41543.52
2020FY-0.440-0.176-0.439560.41548.91
2021FY0.1400.8120.140747.59738.09
2022FY0.1600.155-0.053847.13843.69
2023FY2.0902.0322.3191,0591,061
2024FY2.2202.7940.3571,2001,191
2025FY3.8403.7864.5201,4041,380
2026FY-4.707--1,599
2027FY-5.972--1,818
2028FY-6.960--2,055
2029FY-7.980--2,154

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-11820429.25413.74443.07
2026Q4S2026-11-06920428.77413.74443.07
2026Q4S2026-10-30820428.12413.74443.07
2026Q4S2026-10-29800426.92413.74443.07
2026Q4S2026-10-14800426.92413.74443.07
2026Q4S2026-10-13801426.92413.74443.07
2026Q4S2026-08-14801426.92413.74443.07
2026Q4S2026-08-11901424.61406.17443.07
2026Q4S2026-08-03902424.61406.17443.07
2026Q4S2026-07-31902424.61406.17443.07
2026Q4S2026-07-21901425.61406.17443.07
2026Q4S2026-07-10911425.61406.17443.07
2026Q4S2026-07-07911425.62406.17443.07
2026Q4S2026-06-24911425.62406.17443.07

Estimate history

EPS, annual0.1320.1831.336-0.4390.14-0.0532.3190.3574.5223.9726
Period201720182019202020212022202320242025TTM
EPS, quarterly0.7540.8631.0021.1541.1671.2020.8240.881.067
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual333.764444.938547.405560.412747.59847.1331058.5221194.6151403.6651560.33
Period201720182019202020212022202320242025TTM
Sales, quarterly301.039315.518324.14339.455354.685385.385374.758390.046410.145
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual33.68534.43735.00236.41537.57838.10838.68238.49139.2339.414
Period201720182019202020212022202320242025MRQ
Shares, quarterly38.36338.49138.68438.97139.1539.2339.32539.38939.414
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,560.331,403.661,194.621,058.52847.13747.59560.41547.40444.94
Cost of Goods Sold Incl. D&A519.40482.02444.81385.83320.84274.83223.04176.23153.24
Gross Profit1,040.93921.65749.81672.69526.29472.76337.37371.18291.70
Selling, General and Administrative Excl. Other851.69732.40663.58580.93520.21480.26373.81323.70260.77
Research and Development75.5469.4394.7884.4279.41104.5587.5551.7236.16
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income189.25189.2586.2291.776.08-7.50-36.4447.4730.93
Interest Expense1.271.311.421.74----0.00
Unusual Expense0.000.0076.9418.210.000.002.50-0.0431.79
Net Income Before Taxes207.82205.1220.8779.653.89-10.50-38.0250.131.61
Income Taxes50.8127.446.86-11.305.89-13.12-18.763.13-4.40
Consolidated Net Income157.02177.6914.0190.95-2.002.62-19.2647.002.91
Net Income From Continuing Operations157.02177.6914.0190.95-2.005.28-15.7048.466.60
Net Income157.02177.6914.0190.95-2.005.28-15.7048.466.60
EPS (Recurring)3.964.521.732.64-0.050.14-0.391.340.80
EPS (Basic, Before Extraordinaries)4.004.570.362.37-0.050.14-0.441.390.19
EPS (Diluted)3.974.520.362.32-0.050.14-0.441.340.18
EBITDA209.36210.30113.47122.3733.6611.99-20.7655.3337.10
Non-Operating Income (Expense)19.8417.1913.017.84-2.19-3.000.922.632.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense49.3446.7836.4739.9129.5348.0118.6415.6814.55
Price To Earnings Ratio80.9280.92275.79242.47-2,074.51-122.87806.60
Price To Sales Ratio8.088.707.819.329.9414.5611.1710.889.91
Gross Margin66.7165.6662.7763.5562.1363.2460.2067.8165.56
Operating Margin12.1313.487.228.670.72-1.00-6.508.676.95
Net Margin10.0612.661.178.59-0.240.71-2.808.851.48
Shares Outstanding39.4139.2338.4938.6838.1137.5836.4135.0034.44
Market Capitalization12,670.1512,670.159,114.299,708.548,448.7010,733.936,354.465,735.324,216.27

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue410.14390.05374.76385.38354.69339.45324.14315.52
Cost of Goods Sold Incl. D&A135.24130.65125.86127.65116.69115.56108.36104.90
Gross Profit274.90259.39248.90257.73237.99223.90215.78210.62
Selling, General and Administrative Excl. Other224.16218.35210.67198.50189.16183.07175.43167.84
Research and Development20.0719.9617.9917.5220.3723.2222.0820.01
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income50.7441.0438.2359.2348.8440.8340.3542.77
Interest Expense0.300.310.320.330.340.320.320.34
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes56.3246.1941.6963.6352.3345.3143.8644.34
Income Taxes14.0411.389.1016.296.470.044.6310.66
Consolidated Net Income42.2834.8132.5847.3445.8545.2739.2233.68
Net Income From Continuing Operations42.2834.8132.5847.3445.8545.2739.2233.68
Net Income42.2834.8132.5847.3445.8545.2739.2233.68
EPS (Recurring)1.070.880.821.201.171.151.000.86
EPS (Basic, Before Extraordinaries)1.070.880.831.211.171.171.020.88
EPS (Diluted)1.070.880.821.201.171.151.000.86
EBITDA56.2046.6542.8163.6951.3346.3345.3750.70
Non-Operating Income (Expense)5.885.463.774.733.834.803.831.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.7210.7911.5715.2612.5911.2410.899.56
Price To Earnings Ratio80.9272.6572.5974.3067.17240.70777.35275.79
Price To Sales Ratio8.088.308.938.737.467.878.457.76
Gross Margin67.0366.5066.4266.8867.1065.9666.5766.75
Operating Margin12.3710.5210.2015.3713.7712.0312.4513.56
Net Margin10.318.928.6912.2812.9313.3412.1010.68
Shares Outstanding39.4139.3939.3239.2339.1538.9738.6838.49
Market Capitalization12,670.1512,418.8912,886.2612,175.929,879.259,938.2310,299.549,114.29

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments544.82340.13289.19188.03254.88264.83189.39200.89214.59
Short Term Receivables190.02167.67201.77203.38133.94114.61105.9081.9058.01
Inventories431.55406.74388.02334.01263.50219.53152.99115.7494.90
Other Current Assets50.3036.5936.4230.2829.1618.7314.8512.2014.73
Total Current Assets1,216.68951.12915.40755.70681.47617.70463.13410.73382.23
Net Property, Plant & Equipment317.00268.45292.54290.97227.09127.43135.4535.4130.90
Total Investments and Advances0.000.000.000.000.000.000.000.003.87
Intangible Assets172.94172.34237.33247.21257.0119.0133.0635.0631.96
Deferred Tax Assets79.19100.3385.1664.2165.7050.1431.3032.9426.69
Other Assets40.7240.9425.8812.7912.988.712.950.881.02
Total Assets1,826.521,533.181,556.311,370.891,244.25822.98665.90515.01476.67
Short Term Debt Incl. Current Port. of LT Debt16.2314.5913.4311.959.986.038.310.000.00
Accounts Payable34.7431.3327.1626.6813.4214.1115.118.186.76
Other Current Liabilities132.16112.43110.56106.3099.8085.8067.6357.8944.83
Total Current Liabilities183.13158.34151.14144.93123.20105.9391.0566.0651.58
Long Term Debt203.47208.80220.91223.82163.5771.2573.990.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-----4.784.004.173.30
Other Liabilities12.3215.115.313.283.563.2311.2422.3621.38
Total Liabilities398.92382.25377.36372.03290.32185.19180.2992.5976.26
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,427.601,150.931,178.94998.86953.93641.50485.89422.24400.41
Total Shareholders Equity1,427.601,150.931,178.94998.86953.93641.50485.89422.24400.41
Accumulated Minority Interest0.000.000.000.000.00-3.71-0.280.170.00
Total Equity1,427.601,150.931,178.94998.86953.93637.79485.61422.42400.41
Total Liabilities & Stockholders Equity1,826.521,533.181,556.311,370.891,244.25822.98665.90515.01476.67
Book Value Per Share36.3929.9030.4826.2125.3817.6213.8812.2611.89
Tangible Book Value Per Share31.9825.4224.3419.7218.5517.0912.9411.2410.94
Full-Time Employees4,7004,5004,2003,9003,8003,3002,7002,2001,700
Price to Book Ratio8.008.258.798.6711.329.9311.839.978.32
Return on Assets10.580.916.21-0.150.51-2.118.211.331.19
Return on Equity13.781.208.35-0.210.66-2.7910.671.601.40
Return on Invested Capital10.891.036.50-0.160.47-2.208.661.561.16
Quick Ratio4.293.443.492.913.393.763.414.475.57
Current Ratio6.646.016.065.215.535.835.096.227.41

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income157.02177.6914.0190.95-2.002.62-19.2647.002.91
Depreciation20.1217.4723.7027.2624.3216.4112.898.106.17
Other Funds (Non Cash)61.6965.19170.8977.2742.1071.2743.1326.5756.47
Funds from Operations254.26281.38192.26176.4265.8776.2117.9583.4959.07
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital6.78-42.72-23.78-79.08-121.53-66.71-51.19-56.84-30.26
Cash from Operating Activities261.05238.66168.4897.33-55.669.50-33.2426.6528.81
Capital Expenditures-60.75-63.73-21.18-15.21-19.30-21.18-24.76-22.11-9.60
Net Assets From Acquisitions0.000.000.00-0.990.000.000.000.00-20.41
Sale of Fixed Assets and Businesses0.000.000.000.000.002.920.000.80-
Purchase or Sale of Investments-276.44-340.8697.710.6274.09-3.07-76.3318.0329.63
Purchase of Investments-746.38-355.74-32.91-81.940.00-126.79-153.06-77.33-109.61
Sale Or Maturity of Investments469.9414.88130.6282.5674.09123.7276.7395.36139.24
Other Uses-1.500.000.00-0.500.00-0.40-3.06-8.640.00
Other Sources0.000.001.100.000.000.000.000.000.00
Cash from Investing Activities-338.69-404.5977.62-16.0854.79-21.73-104.15-11.91-0.39
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock17.2531.82-83.2120.4121.5518.37151.3013.1012.29
Repurchase of Common Pref Stock0.000.00-100.390.000.000.000.000.000.00
Sale of Common Pref Stock17.2531.8217.1720.4121.5518.37151.3013.1012.29
Proceedsfrom Stock Options0.000.000.000.000.000.00134.760.000.00
Issuance or Reduction of Debt, Net-2.41-2.48-2.28-1.98-1.75-1.45-3.42-2.570.00
Change in Long Term Debt-2.41-2.48-2.28-1.98-1.75-1.45-3.42-2.570.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt-2.41-2.48-2.28-1.98-1.75-1.45-3.42-2.570.00
Net Financing Active Other Cash Flow-3.72-2.80-1.52-2.23-8.18-16.08-12.96-20.29-22.11
Other Financing Activities Uses-3.72-2.80-1.52-2.23-8.18-16.08-12.96-20.29-22.61
Cash from Financing Activities11.1226.53-87.0116.2011.620.84134.92-9.76-9.81
Exchange Rate Effect-0.221.89-2.180.17-0.271.11-0.64-0.05-1.40
Net Change in Cash-66.75-137.51156.9297.6310.48-10.29-3.114.9317.21
Free Cash Flow200.29174.93147.3082.12-74.96-11.68-58.004.5419.20
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow62.9769.8363.31120.12---1,311.34229.62
Deferred Taxes & Investment Tax Credit-21.03-16.34-19.061.46-14.09-18.821.82-6.48

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments673.61658.79615.66544.82470.30424.56
Short Term Receivables195.22190.41183.29190.02183.43175.54
Inventories459.13442.65438.54431.55432.37427.63
Other Current Assets48.6752.2737.9150.3055.4337.76
Total Current Assets1,376.631,344.121,275.411,216.681,141.521,065.48
Net Property, Plant & Equipment344.30338.27329.54317.00295.24286.49
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets172.03172.26172.53172.94173.12173.30
Deferred Tax Assets79.2279.3879.9779.1994.48109.14
Other Assets52.9240.6940.9840.7240.0240.39
Total Assets2,025.101,974.721,898.441,826.521,744.371,674.81
Short Term Debt Incl. Current Port. of LT Debt17.0816.7816.5316.2315.5115.25
Accounts Payable41.9644.7343.6634.7429.8228.12
Other Current Liabilities174.77172.27151.54132.16124.27114.39
Total Current Liabilities233.81233.78211.73183.13169.60157.76
Long Term Debt192.31195.93199.65203.47201.54205.28
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities15.4814.2513.2512.3214.5317.82
Total Liabilities441.59443.96424.63398.92385.67380.86
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,583.511,530.771,473.811,427.601,358.701,293.95
Total Shareholders Equity1,583.511,530.771,473.811,427.601,358.701,293.95
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,583.511,530.771,473.811,427.601,358.701,293.95
Total Liabilities & Stockholders Equity2,025.101,974.721,898.441,826.521,744.371,674.81
Book Value Per Share40.1838.8637.4836.3934.7033.20
Tangible Book Value Per Share35.8134.4933.0931.9830.2828.76
Full-Time Employees---4,700--
Price to Book Ratio8.008.439.028.967.638.19
Return on Assets8.338.809.8010.5810.189.20
Return on Equity10.6711.3712.7313.7813.3212.03
Return on Invested Capital2.382.021.952.902.943.02
Quick Ratio3.923.863.954.294.184.04
Current Ratio5.895.756.026.646.736.75

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income42.2834.8132.5847.3445.8545.27
Depreciation5.475.624.574.462.495.51
Other Funds (Non Cash)17.2913.2715.0716.0617.2115.20
Funds from Operations65.4954.3551.5082.9280.2759.23
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-23.98-8.2735.473.56-22.00-14.28
Cash from Operating Activities41.5146.0886.9786.4858.2644.95
Capital Expenditures-15.11-13.54-13.67-18.43-16.25-15.58
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments24.29-77.55-15.96-207.21-146.61-0.00
Purchase of Investments-179.99-216.19-141.10-209.09-146.61-0.00
Sale Or Maturity of Investments204.28138.65125.141.880.000.00
Other Uses-0.500.00-1.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities8.68-91.09-30.63-225.65-162.86-15.58
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.009.670.007.584.6515.57
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.009.670.007.584.6515.57
Proceedsfrom Stock Options-9.679.670.000.000.000.00
Issuance or Reduction of Debt, Net-0.61-0.62-0.62-0.57-0.61-0.69
Change in Long Term Debt-0.61-0.62-0.62-0.57-0.61-0.69
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.61-0.62-0.62-0.57-0.61-0.69
Net Financing Active Other Cash Flow-0.45-0.03-1.29-1.95-0.09-0.06
Other Financing Activities Uses-0.45-0.03-1.29-1.95-0.09-0.06
Cash from Financing Activities-1.069.03-1.915.063.9514.82
Exchange Rate Effect-0.12-0.04-0.04-0.03-0.091.53
Net Change in Cash49.01-36.0254.39-134.13-100.7445.71
Free Cash Flow26.4032.5473.3068.0542.0129.37
Price to Free Cash Flow62.9757.8761.0470.0165.2362.32

Revenue breakdown

Embolization2024: 379.14M 2025: 455.75M
Thrombectomy2024: 815.48M 2025: 947.92M
Non-US2024: 292.55M 2025: 311.90M
United States2024: 902.07M 2025: 1.09B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.28%2.4M38.3M345.41K
2026-10-155.91%2.3M38.3M344.93K
2026-09-305.87%2.2M38.3M345.51K
2026-09-154.72%1.8M38.3M331.90K
2026-08-314.53%1.7M38.2M361.49K
2026-08-144.75%1.8M38.3M389.90K
2026-07-314.80%1.8M38.3M413.47K
2026-07-155.56%2.1M38.2M437.99K
2026-06-305.33%2.0M38.2M465.94K
2026-06-155.21%2.0M38.1M506.02K
2026-05-295.01%1.9M38.2M543.87K
2026-05-155.02%1.9M38.2M566.99K
2026-04-304.98%1.9M38.1M660.11K
2026-04-155.27%2.0M38.1M856.07K
2026-03-316.40%2.4M38.1M1.04M
2026-03-135.42%2.1M38.0M992.67K
2026-02-274.91%1.9M38.0M956.59K
2026-02-134.90%1.9M38.0M941.49K
2026-01-304.21%1.6M38.0M878.68K
2026-01-154.53%1.7M38.0M650.47K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1601401800.0011.2730.000.000.997-0.0680.005
call1651351750.0010.8960.000.000.995-0.0880.007
call1701301700.0010.5390.000.000.995-0.0880.008
call1751251650.0010.2000.000.000.993-0.1060.010
call1801201600.009.8760.000.000.993-0.1060.010
call1851151550.009.5680.000.000.989-0.1550.015
call1901101500.009.2730.000.000.988-0.1550.016
call1951051450.008.9890.000.000.988-0.1550.016
call2001001400.008.7170.000.000.987-0.1540.017
call21090.001300.008.2020.000.000.979-0.2210.026
call22080.001200.007.7200.000.000.976-0.2310.029
call23070.001100.007.2680.000.000.972-0.2390.033
call24060.001000.006.8410.000.000.967-0.2460.038
call25050.0090.000.002.8820.000.000.961-0.2530.043
call26040.0080.000.002.3090.000.000.956-0.2460.047
call27030.0070.000.002.3950.000.000.949-0.2370.053
call28020.0060.000.002.1560.000.000.940-0.2270.060
call29010.0050.000.001.9200.000.000.927-0.2140.070
call3000.0040.0022.301.6931.000.000.801-0.4670.141
call3100.0040.0013.808.3087.000.000.620-2.9900.193
call3200.003.5026.301.9402.000.000.553-1.4580.201
call3300.000.200.10-24.000.00---
call3400.000.1010.500.20411.000.000.247-0.4310.160
call3500.000.101.800.25713.000.000.069-0.1310.067
call3600.0040.005.000.36614.000.000.029-0.0680.033
call3700.0040.000.500.43920.000.000.024-0.0710.029
call3800.0040.007.000.50919.000.000.021-0.0740.026
call3900.0040.005.600.5756.000.000.019-0.0760.024
call4000.0040.002.900.6383.000.000.018-0.0780.022
call4100.0040.0017.100.6996.000.000.016-0.0800.021
call4200.0040.005.400.7575.000.000.015-0.0820.019
call4300.0040.004.400.8143.000.000.014-0.0830.018
call4400.0040.004.400.8684.000.000.014-0.0850.018
call4500.0040.005.700.9217.000.000.013-0.0860.017
call4600.0040.006.000.9722.000.000.012-0.0870.016
call4700.0040.001.001.02217.000.000.012-0.0880.016
call4800.0040.004.401.0709.000.000.011-0.0890.015
put1600.000.100.051.6116031.00-0.002-0.0280.003
put1650.000.200.151.6706.000.00-0.004-0.0500.005
put1700.000.150.10-15.000.00---
put1750.000.300.50-11.000.00---
put1800.000.100.101.58422.000.00-0.007-0.0860.010
put1850.000.408.50-1.000.00---
put1900.000.250.401.56332.000.00-0.012-0.1340.016
put1950.000.500.45-1.000.00---
put2000.000.350.50-53.000.00---
put2100.000.600.65-28.000.00---
put2200.000.650.65-24.000.00---
put2300.000.7016.40-9.000.00---
put2400.000.750.20-25.000.00---
put2500.000.800.90-2490.00---
put2600.000.851.00-27.000.00---
put2700.000.900.550.71426.001.00-0.051-0.2080.053
put2800.000.951.00-14.000.00---
put2900.201.000.500.50143.000.00-0.084-0.2130.078
put3000.151.100.50-1330.00---
put3100.000.801.000.2852610.00-0.344-0.7300.186
put3200.003.006.000.7447.000.00-0.450-0.4810.201
put3300.0020.0067.00-19.000.00---
put3400.0040.0076.907.6993.000.00-0.516-2.0450.202
put35010.0050.0086.807.2781.000.00-0.742-0.6410.164
put36020.0060.001126.8696.000.00-0.971-0.0280.033
put37030.0070.00133.66.4729.000.00-0.976-0.0300.029
put38040.0080.00149.26.08410.000.00-0.979-0.0320.026
put39050.0090.00153.25.7033.000.00-0.981-0.0330.024
put40060.001001625.3261.000.00-0.982-0.0340.022
put41070.00110134.95.4480.000.00-0.984-0.0340.021
put42080.00120194.85.5650.000.00-0.985-0.0350.019
put43090.00130178.655.6770.000.00-0.986-0.0350.018
put4401001401965.7850.000.00-0.986-0.0360.018
put450110150186.35.8890.000.00-0.987-0.0360.017
put4601201602065.9900.000.00-0.988-0.0360.016
put4701301702246.0860.000.00-0.988-0.0360.016
put4801401802366.1800.000.00-0.989-0.0360.015

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-06SCHEDULE 13G/ASEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-13SCHEDULE 13GSEC
2026-07-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-07425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-05-078-KCurrent report2026-05-06SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-30SCHEDULE 13GSEC
2026-04-29DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-18SEC
2026-04-29ARSAnnual report to security holders. 2025-12-31SEC
2026-04-23425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-04-22425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-04-17425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-04-064Statement of changes in beneficial ownership of securities2026-04-02SEC
2026-04-02144Filing for proposed sale of securities under Rule 144.SEC
2026-04-01DEFM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-03-27SCHEDULE 13G/ASEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-15SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-15SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040032.82K1
2026-0300832.47K1
2026-020000
2026-0100115.94K2
2025-12004.93M4
2025-11005.17M5

Institutional holders

Manager% owned
BlackRock, Inc.10.93%
HBK INVESTMENTS L P4.67%
VANGUARD CAPITAL MANAGEMENT LLC4.35%
VANGUARD PORTFOLIO MANAGEMENT LLC4.24%
UBS Group AG3.72%
STATE STREET CORP3.16%
ExodusPoint Capital Management, LP2.77%
BALYASNY ASSET MANAGEMENT L.P.2.77%
JPMORGAN CHASE & CO2.72%
GOLDMAN SACHS GROUP INC2.15%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF3.42%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.02%
North Carolina Tax-Free Income Series2.67%
VANGUARD SMALL-CAP INDEX FUND2.18%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.26%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
SMALLCAP World Fund Inc1.05%
Invesco S&P MidCap Quality ETF0.78%
State Street SPDR S&P MidCap 400SM ETF Trust0.77%
iShares S&P Mid-Cap 400 Growth ETF0.60%

OakChart. PEN. Cached 15 minutes.